← Back to the fund page Use your browser's print dialog and choose “Save as PDF”. A4.
InvestVerdict

Baroda BNP Paribas Health and Wellness Fund

Regular Plan · Growth Option · Sectoral / Thematic · Scheme code 153602

Fund houseBaroda BNP Paribas Mutual Fund
CategorySectoral / Thematic
Plan & optionRegular · Growth Option
History1.2 years

Returns (%)

 1M3M6M1Y3Y5Y7Y10YLaunch
This scheme 1.3110.2813.54 12.09—— ——7.36
Nifty 500
benchmark
0.874.312.15 5.2012.4911.41 ——15.49
Sectoral / Thematic
category median
——— -6.5811.548.85 —12.68—

Over a year annualised (CAGR), under a year absolute. Computed from AMFI's published NAV history for this scheme.

Risk

 VolatilitySharpeSortinoBetaAlphaMax fallR²
This scheme 13.2% 0.07 0.09 0.50 2.08% -11.9% 40.20
Nifty 500
benchmark
15.2%0.39 0.58—— -37.3%—

Risk-free rate 6.5%. Beta, alpha and R² are regressed on the 13 months this scheme and its benchmark share.

Growth of ₹100 since launch

88951031102026InvestVerdict

Drawdown from peak (%)

0%-4%-9%-13%2026

Every one-year period it has lived through

WindowsWorstMedianBestPeriods that lost money
43 2.1% 6.2% 12.1% 0%

Every one-year holding period in this scheme's history, not just the last one — the spread a real investor would have met depending only on when they started.

How it behaves against its benchmark

Up captureDown captureCorrelation Tracking errorInformation ratioTreynor
88% 66% 0.63 13.2% 0.27 1.03

Up capture is how much of the benchmark's gain this scheme kept in the months the benchmark rose; down capture, how much of its fall it took. Below 100 on the down side and above it on the up side is the combination every fund is trying for and few reach. Measured over the 13 months this scheme and Nifty 500 share.

InvestVerdict

Baroda BNP Paribas Health and Wellness Fund

Regular Plan · Growth Option

Allocation

By asset

Equity97.06%
Cash & Equivalents2.94%

By market cap

Large Cap31.13%
Mid Cap45.10%
Small Cap18.13%
Unclassified2.70%

Concentration

Number of stocks33
Top 5 stocks36.50%
Top 10 stocks58.36%
Top 20 stocks83.31%
Lines in the filing35
Largest holding8.58%
Largest sectorPharmaceuticals & Biotechnology 73.65%
Effective stocks22.1
Sectors held4
Cash2.94%

Effective stocks is what the concentration works out to: a fund holding 33 names but most of its money in a few behaves like a fund of 22. Cash includes repo and TREPS, which every fund parks money in overnight.

Sector split

Pharmaceuticals & Biotechnology — 73.7%Healthcare Services — 19.8%Other — 6.5%Pharmaceuticals & Biotech…73.7%Healthcare Services19.8%Other6.5%
Pharmaceuticals & Biotechnology73.65%
Healthcare Services19.83%
2.78%
Insurance2.68%
IT - Services0.90%
Cash & Equivalents0.16%
InvestVerdict

Baroda BNP Paribas Health and Wellness Fund

Regular Plan · Growth Option · holdings

Top 30 holdings

#CompanySectorShares held Value
₹ cr
% of fund
1 Sun Pharmaceutical Industries Limited Pharmaceuticals & Biotechnology 230,250 42 8.58%
2 Torrent Pharmaceuticals Limited Pharmaceuticals & Biotechnology 80,000 38 7.88%
3 Divi's Laboratories Limited Pharmaceuticals & Biotechnology 41,000 38 7.82%
4 IPCA Laboratories Limited Pharmaceuticals & Biotechnology 155,000 30 6.13%
5 Laurus Labs Limited Pharmaceuticals & Biotechnology 150,000 30 6.09%
6 Lupin Limited Pharmaceuticals & Biotechnology 139,000 28 5.79%
7 Apollo Hospitals Enterprise Limited Healthcare Services 31,500 26 5.28%
8 Fortis Healthcare Limited Healthcare Services 252,000 19 3.98%
9 Dr. Lal Path Labs Limited Healthcare Services 85,000 17 3.47%
10 Mankind Pharma Limited Pharmaceuticals & Biotechnology 65,000 16 3.34%
11 Glenmark Pharmaceuticals Limited Pharmaceuticals & Biotechnology 65,000 15 3.11%
12 Aurobindo Pharma Limited Pharmaceuticals & Biotechnology 90,000 15 3.09%
13 AstraZeneca Pharma India Limited Pharmaceuticals & Biotechnology 22,000 14 2.79%
14 Clearing Corporation of India Ltd — 14 2.78%
15 Abbott India Limited Pharmaceuticals & Biotechnology 4,500 12 2.50%
16 Emcure Pharmaceuticals Limited Pharmaceuticals & Biotechnology 60,000 12 2.39%
17 Acutaas Chemicals Limited Pharmaceuticals & Biotechnology 35,000 11 2.36%
18 Zydus Lifesciences Limited Pharmaceuticals & Biotechnology 94,000 11 2.24%
19 Max Financial Services Limited Insurance 78,498 11 2.21%
20 Aster DM Quality Care Limited Healthcare Services 150,000 10 2.15%
21 Concord Biotech Limited Pharmaceuticals & Biotechnology 75,000 10 2.11%
22 Ajanta Pharma Limited Pharmaceuticals & Biotechnology 21,000 8 1.56%
23 Symbiotec Pharmalab Limited Pharmaceuticals & Biotechnology 60,720 7 1.47%
24 Nephrocare Health Services Ltd Healthcare Services 105,000 7 1.42%
25 Metropolis Healthcare Limited Healthcare Services 120,000 7 1.33%
26 Dr. Reddy's Laboratories Limited Pharmaceuticals & Biotechnology 50,000 6 1.26%
27 Manipal Health Enterprises Ltd Healthcare Services 84,750 6 1.23%
28 Gland Pharma Limited Pharmaceuticals & Biotechnology 20,000 6 1.19%
29 Cipla Limited Pharmaceuticals & Biotechnology 40,000 5 1.10%
30 Narayana Hrudayalaya Limited Healthcare Services 26,500 5 0.97%
InvestVerdict

Baroda BNP Paribas Health and Wellness Fund

Regular Plan · Growth Option · where the money sits

Not investment advice. InvestVerdict is not a SEBI-registered Investment Adviser or Research Analyst. Every figure is computed from AMFI's published NAV history and the portfolio the AMC filed with AMFI; none of it is a recommendation to buy, hold or sell. Past returns do not predict future ones. Generated 2 Nov 2026.